Wealthcare Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-234
Closed -$212K 87
2024
Q2
$212K Buy
+234
New +$187K 0.02% 81
2021
Q2
Sell
-161
Closed -$30K 398
2021
Q1
$30K Buy
+161
New +$31.5K ﹤0.01% 184
2020
Q2
Sell
-2
Closed 153
2020
Q1
$0 Sell
2
-58
-97% -$7.97K ﹤0.01% 474
2019
Q4
$8K Buy
+60
New +$6.96K ﹤0.01% 205
2015
Q3
Sell
-135
Closed -$11K 329
2015
Q2
$11K Sell
135
-535
-80% -$40.8K ﹤0.01% 195
2015
Q1
$49K Buy
+670
New +$47.7K 0.01% 256

Other funds holding LLY

Wealthcare Capital Management's LLY Position: Q3 2024 in Review

Wealthcare Capital Management sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 234 shares — an estimated $212K sold.

Wealthcare Capital Management first reported a position in LLY in Q1 2015 and held it in 6 quarters. The position peaked at $212K in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Wealthcare Capital Management reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • Wealthcare Capital Management sold 234 Eli Lilly shares in Q3 2024, an estimated $212K.
  • Wealthcare Capital Management first reported a position in Eli Lilly in Q1 2015 and held it in 6 quarters.
  • Wealthcare Capital Management's Eli Lilly position peaked at $212K in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Wealthcare Capital Management's 13F filing for Q3 2024, filed 4 Nov 2024.